NCT02995161 is a NA clinical trial of BAY987521 in Sunscreening Agents, sponsored by Bayer.

Who is sponsoring NCT02995161?

NCT02995161 is sponsored by Bayer.

What drugs are being tested in NCT02995161?

Interventions in NCT02995161: BAY987521, SPF control.

What condition does NCT02995161 study?

NCT02995161 studies Sunscreening Agents.

Is NCT02995161 still recruiting?

NCT02995161 is currently completed. Last updated 27 February 2018.

Last reviewed 2018-02-27 · How we verify

NCT02995161

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sun Protection Factor Assay (344/2016)

Completed NA Last updated 27 February 2018

What this trial tests

NA trial testing BAY987521 in Sunscreening Agents in 10 participants. Completed in 4 January 2017.

Timeline

30 December 2016

Primary endpoint
4 January 2017

4 January 2017

Quick facts

Lead sponsor	Bayer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	10
Start date	30 December 2016
Primary completion	4 January 2017
Estimated completion	4 January 2017
Sites	1 location across United States

Drugs / interventions tested

BAY987521 — full drug profile →
SPF control — full drug profile →

Conditions studied

Sunscreening Agents — all drugs for Sunscreening Agents →

Sponsor

Bayer — full company profile →

Who can join

Adults 18 to 70, any sex, with Sunscreening Agents. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the Sun Protection Factor efficacy on human skin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of BAY987521

Trials testing the same drug.

NCT02995109 — Sun Protection Factor Assay (338/2016) · NA · completed
NCT02995044 — Sun Protection Factor Assay (319/2016) · NA · terminated
NCT02995018 — Sun Protection Factor Assay (317/2016) · NA · completed
NCT02995031 — Sun Protection Factor Assay (318/2016) · NA · terminated
NCT02995148 — Sun Protection Factor Assay (343/2016) · NA · completed

Other Bayer trials

Trials by the same sponsor.

NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02995161 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayer
Last refreshed: 27 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02995161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing